Who are the key players in India Pharmaceutical Market? What years does this India Pharmaceutical Market cover, and what was the market size in 2023? What are the key government initiatives driving India's Pharma Industry growth? What are the key government initiatives driving India's Pharma...
e-pharma presents a total addressable market size of US$ 9.3 billion as of 2019 and is estimated to grow at a CAGR of 18.1% to reach US$18.1billion by 2023. Interestingly, 35% of the domestic pharmaceutical market relates to chronic medications and the remaining 65% to acute medicines. Ou...
Ani Healthcare Private Limited excels as a market specialist in the pharmaceuticals and veterinary industry in most of the regions of the country. It primarily produces pharma and veterinary products such as tablets, capsules, injections, feed supplements, soaps, liquids, and syrups. Presently, the...
Indian pharmaceutical market is expected to grow to US$ 130 billion by 2030, stated DV Sadananda Gowda, minister for chemicals and fertilizers, Government of india at the curtain raiser event of 6th edition of annual programme on Pharmaceuticals & Medical Device sector –‘India Pharma & India Me...
Emcure Pharmaceutical Pvt. Ltd. (India), Cipla Ltd. (India), Gland Pharma Limited (India), Troikaa Pharmaceuticals Ltd. (India), and Biological E Limited (India) have been identified as the top players in this market. These companies have a broad product portfolio with comprehensive features....
The medtech industry in India is currently at a turning point with growth opportunities. Key strengths such as market size, cost-effective manufacturing, a skilled workforce and a thriving startup ecosystem lay a foundation for expanding the industry. By 2025, the Indian MedTech market ...
The factors that influenced MNCs to focus on the Indian market include the growth in revenues by 15 percent in 2011 and increase in trends in marketing and distribution of Indian drug companies. The size, rank, and value of the drug industry globally are mentioned....
The overall Indian market for medical devices and diagnostics stands at Rs 77,540 crore for the year 2019-20. In 2018-19 the overall market was Rs 72,000 crore growing at 7 per cent over the previous year’s market size of Rs 66,400 crore. According to Inves...
Aurobindo Pharma's subsidiary, Eugia Pharma, gets USFDA nod for cancer drug Pazopanib. The drug treats renal cell carcinoma and soft tissue sarcoma. Launch expected in Q4FY25. The market size is estimated at USD 106 million. Aurobindo's shares closed slightly lower on Thursday. The drug is ...
Focuses on the release of a report on the issues and opportunities in the pharmaceuticals, biotechnology and healthcare sectors in India by Ernst & Young International. Status of the merger and acquisition activity in the generics industry; Factors that drive changes in the distribution structure of...